Primary hyperparathyroidism

Al-Azem, Hafsah; Khan, Aliya
July 2011
CMAJ: Canadian Medical Association Journal;7/12/2011, Vol. 183 Issue 10, pE685
Academic Journal
Case Study
The article presents a case study of a 17-year-old male with thirst, lethargy, and fatigue. Laboratory analysis was done on patient's serum level of calcium, level of ionized calcium, and level of parathyroid hormone. It revealed that the patient was diagnosed with hypercalcemia and primary hyperparathyroidism due to the elevate level of parathyroid hormone.


Related Articles

  • Lithium Therapy and Hyperparathyroidism: An Evidence-Based Assessment. Saunders, Brian D.; Saunders, Erika F. H.; Gauger, Paul G. // World Journal of Surgery;Nov2009, Vol. 33 Issue 11, p2314 

    Prolonged therapeutic exposure to lithium compounds can have adverse consequences on calcium homeostasis. A unique form of hyperparathyroidism appears to be causally linked to chronic lithium exposure. We provide a comprehensive review of relevant literature using a structured, evidence-based...

  • Parathyroid Disorders. MICHELS, THOMAS C.; KELLY, KEVIN M. // American Family Physician;8/15/2013, Vol. 88 Issue 4, p249 

    The article explores the disorders of the parathyroid glands. Named as the most common cause of hypercalcemia in outpatients, primary hyperparathyroidism is often discovered during evaluation of serum electrolyte levels and about 85 percent of patients affected with the said disease have a...

  • Hiperparatiroidismo primario: presentación de un caso y revisión de la literatura. VON FURSTENBERG, CAROLINA GARFIAS; VILLANUEVA, SOLEDAD T.; UGARTE, FRANCISCA P. // Revista Chilena de Pediatría;jul/ago2011, Vol. 82 Issue 4, p336 

    Hypercalcemia is infrequent in pediatrics, causes include mutations of calcium sensing receptor (CaSRs), PT adenoma or hyperplasia, D or A hypervitaminosis, inborn errors of metabolism, parenteral nutrition, and others. Objective: To report a case of severe hypercalcemia in a adolescent due to...

  • The Prevalence of Familial Hypocalciuric Hypercalcemia. Hinnie, J.; Bell, E.; McKillop, E.; Gallacher, S. // Calcified Tissue International;Apr2001, Vol. 68 Issue 4, p216 

    Familial hypocalciuric hypercalcamia is said to be an extremely rare condition but is clinically important because it can be confused with primary hyperparathyroidism. The biochemical features of the two conditions are similar, but the former is benign while the latter can have serious clinical...

  • Severe Hypercalcemia Mimicking Primary Hyperparathyroidism in the Context of Thyrotoxicosis: A Case Report. Gundroo, Abrar; Meeran, Karim // Journal of Endocrinology & Metabolism;2013, Vol. 3 Issue 6, p147 

    We report a case of a 27-year-old woman who presented to our endocrinology clinic with two episodes of severe and symptomatic hypercalcemia associated with thyrotoxicosis in Graves' disease. The degree of hypercalcemia (3.34 mmol/L) is the most significant we have seen documented in the...

  • Bilateral Giant Mediastinal Parathyroid Adenomas Presented With Severe Hypercalcemia: Report of a Case. Bayraktar, Baris; Demiral, Gokhan; Ozemir, Ibrahim Ali; Bayraktar, Onur; Yilmabasar, Mehmet Gokce; Boluk, Salih // Journal of Medical Cases;2014, Vol. 5 Issue 3, p167 

    Primary hyperparathyroidism (PHPT) is a common disorder of parathyroid gland and mostly results from parathyroid adenoma with the excess production of parathyroid hormone, usually causing hypercalcemia. This is the most common reason for surgical removal of parathyroid glands. It is mostly seen...

  • Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. Indridason, Olafur S.; Heath III, Hunter; Khosla, Sundeep; Yohay, Daniel A.; Quarles, L. Darryl // Kidney International;Nov1996, Vol. 50 Issue 5, p1663 

    To determine the relative importance of parathyroid gland enlargement and alterations in calcium sensing (set-point changes) in the pathogenesis of uremic secondary hyperparathyroidism (2°HPT), we investigated the relationship between estimates of parathyroid gland size and calcium-mediated...

  • Clinical Importance of Calcium-Sensing Receptor Gene Polymorphism Arg990Gly in the Age of Calcimimetic Therapy. Rothe, Hansjörg; Mayer, Gert // Current Pharmacogenomics;Jun2006, Vol. 4 Issue 2, p153 

    Cinacalcet HCl is the first calcimimetic agent available for the therapy of secondary hyperparathyroidism (sHPT) and palliative treatment of parathyroid carcinoma. It acts on the extracellular calcium-sensing receptor (CaSR) as an allosteric activator, i.e. it leads to responses as if...

  • Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid. Polyzos, Stergios A.; Anastasilakis, Athanasios D.; Terpos, Evangelos // Supportive Care in Cancer;Oct2009, Vol. 17 Issue 10, p1329 

    A letter to the editor is presented in response to the article "Hyperparathyroidism Secondary to Zoledronic Acid Infusion: Case Report" by M. Sayin and G. Yazici.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics